328 W. Claiborne St.
P.O. Box 964
Monroeville, Alabama 36460
(251) 575-4203
Health Policy & Advocacy
Basic InformationMore InformationLatest News
FDA Considers Lowering Nicotine Levels in CigarettesDoctors Facing Challenge to Help Needy While Protecting PracticesPharmacists Encouraged to Learn More About Herbal SupplementsBan Menthols to Help Some Smokers QuitStem Cell Clinics Pitch Pricey, Bogus 'Cures' for Knee PainMany Americans Think Docs Order Too Many Tests, MedsIs Herbal Drug Kratom a Health Friend or Foe?Early Studies Often Show Exaggerated Treatment EffectStrong Tobacco Laws May Weed Out Vapers, TooUnderstanding Rx Nonadherence Can Improve AdherenceBystander Use of Defib Device Doubles Chances of Surviving Cardiac ArrestNew Research Debunks Two Medical Marijuana MythsTake Early Clinical Trials With a Grain of SaltCould Hackers Target Heart Devices?Protecting Your Electronic Health RecordsAfter Another Shooting Tragedy, 'Stop the Bleed' Kits Urged for SchoolsPatients Want Physicians to Have Greater ConnectivityYour Tax Dollars Fund Research on Hundreds of New MedsFour Best Practices Outlined to Prevent Health Care CyberattacksMany Patients Know Too Little About Their MRI, CT Scans: StudyUnsafe Water Found in Faucets Across the U.S.Health Tip: Prevent Exposure to LeadHealth Tip: Online Pharmacies You Should AvoidDon't Count on an American to Do CPRPoll: Personal Beliefs Shouldn't Allow Doctors to Refuse to TreatFDA Says U.S. Will Now Produce Critical MRI ComponentPicking a New Primary Care DoctorUber, Lyft Rides May Not Help Boost Doc Visits for Poorer Patients2018 Immunization Schedule Issued for U.S. ChildrenA Hidden Source of 'Superbugs' in Hospitals?2018 Immunization Schedule Issued for U.S. AdultsTop Three Challenges Identified for Pharmacists in 2018Responding to Opioid Crisis, FDA Puts More Restrictions on ImodiumMonkey Deaths Prompt FDA Probe, New Controls on Animal ResearchCDC: Many U.S. Adults Have Never Been Tested for HIVHealth Tip: Performing CPRPublic Health Workforce to See Large TurnoverSevere Flu Season, Tough Winter a Double Whammy for Blood Banks24-Hour Primary Care Clinics Would Improve Continuity of CareBrochure Can Improve Opioid Disposal Rates After SurgeryReminder, Recall Systems Improve Immunization UptakeSatisfaction Higher in Providers Who E-Mail PatientsRestaurant Bans Have Big Impact on Smoking RatesReduce Legal Blood-Alcohol Limit to Cut Drunk Driving Deaths: ReportFrom Birth On, One Sex Is HardierIs Obesity Slowing Gains in U.S. Life Spans?Health Tip: Perform Regular Skin ChecksFewer Hospitals Closed After Obamacare Expanded MedicaidProgress in Fighting Antibiotic Resistance Shown in CDC MapUSPSTF Questions Adolescent Idiopathic Scoliosis Screening
Related Topics

Health Insurance

Many Dermatology Guideline Authors Get Industry Payments

HealthDay News
Updated: Oct 18th 2017

new article illustration

WEDNESDAY, Oct. 18, 2017 (HealthDay News) -- Many authors of dermatology clinical practice guidelines receive industry payments, and these payments are often not accurately disclosed, according to a study published online Oct. 18 in JAMA Dermatology.

Jake X. Checketts, from Oklahoma State University in Tulsa, and colleagues retrieved three American Academy of Dermatology guidelines published from 2013 to 2016. The Open Payments database was used to identify financial payments received by 49 guideline authors.

The researchers found that 40 of the 49 authors received at least one reported industry payment; 31, 25, and 18 accepted more than $1,000, more than $10,000, and more than $50,000, respectively. Per author, financial payments amounted to a mean of $157,177. Among the 49 authors, the total reimbursement was $7,701,681 from 2013 to 2015. Twenty-two of the 40 authors who received payments did not accurately disclose industry relationships. The authors received payments from companies with products directly related to the guideline topics. There were violations to the administrative regulations.

"Dermatology clinical practice guideline authors received sizable industry payments and did not completely disclose these payments," the authors write. "The American Academy of Dermatology policies may benefit from stricter enforcement or the adoption of new standards."

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

328 W. Claiborne St.
P.O. Box 964
Alabama 36460
Tel: (251)575-4203

powered by centersite dot net